文献速递脊柱外科骨质疏松与代谢性骨病创伤骨科

强直性脊柱炎患者骨折与骨质疏松的患病率及相对风险:系统评价与荟萃分析

Prevalence and relative risk of fractures and osteoporosis in patients with ankylosing spondylitis: a systematic review and meta-analysis.
PubMed 文献 · Osteoporos Int · 2026-01-23

该荟萃分析纳入28项研究,评估强直性脊柱炎(AS)患者骨折和骨质疏松的患病率及相关风险因素。AS患者总体骨折患病率为13%(95%CI:9%-17%),椎体骨折为14%(95%CI:9%-19%),骨质疏松为14%(95%CI:10%-19%)。AS与椎体骨折(OR=2.26;95%CI:1.70-3.00)和非椎体骨折(OR=1.24;95%CI:1.02-1.50)显著相关,BASDAI和mSASSS评分与骨折风险显著相关。

要点

  • AS患者总体骨折、椎体骨折和骨质疏松患病率均超过13%
  • AS显著增加椎体骨折(OR=2.26)和非椎体骨折(OR=1.24)风险
  • BASDAI和mSASSS评分与骨折风险显著相关,可用于早期筛查

核心结论

  • 强直性脊柱炎显著增加患者骨折和骨质疏松风险,BASDAI和mSASSS评分系统有助于预测骨折风险并加强早期识别和监测。

研究设计与样本

  • 系统检索PubMed、Embase、Cochrane Library和Web of Science截至2024年10月10日的流行病学研究,最终纳入28项研究,采用固定或随机效应模型合并效应量,并进行亚组分析、敏感性分析及发表偏倚评估。

主要发现

  • AS患者总体骨折患病率为13%(95%CI:9%-17%),椎体骨折患病率为14%(95%CI:9%-19%),骨质疏松患病率为14%(95%CI:10%-19%)。
  • AS与椎体骨折显著相关(OR=2.26;95%CI:1.70-3.00),与非椎体骨折显著相关(OR=1.24;95%CI:1.02-1.50)。
  • BASDAI与骨折风险显著相关(OR=1.05;95%CI:1.02-1.08),mSASSS与骨折风险显著相关(OR=1.04;95%CI:1.01-1.06),而BASFI和BASRI与骨折风险无显著关联。

关键数值与推荐

  • AS患者总体骨折患病率13%(95%CI:9%-17%),椎体骨折患病率14%(95%CI:9%-19%),骨质疏松患病率14%(95%CI:10%-19%)。
  • AS与椎体骨折的OR=2.26(95%CI:1.70-3.00),与非椎体骨折的OR=1.24(95%CI:1.02-1.50)。
  • BASDAI与骨折风险的OR=1.05(95%CI:1.02-1.08),mSASSS与骨折风险的OR=1.04(95%CI:1.01-1.06)。

临床怎么用

  • 对AS患者应早期筛查骨折和骨质疏松,重点关注BASDAI和mSASSS评分较高的患者,以加强并发症的早期识别和监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with ankylosing spondylitis are at greater risk of fractures and osteoporosis. This meta-analysis reveals their fracture and osteoporosis prevalence exceeds 13%. Two clinical indices, BASDAI and mSASSS, significantly correlate with fracture risk. These findings support early screening and targeted management to prevent skeletal complications and improve patient outcomes. Patients with Ankylosing Spondylitis (AS) face an elevated risk of fractures and osteoporosis, which negatively impact quality of life and increase healthcare costs. This study systematically evaluates the prevalence of these conditions in AS patients and analyzes the associated risk factors. As of October 10, 2024, we conducted a systematic search of PubMed, Embase, the Cochrane Library, and Web of Science for epidemiological studies on the risk factors or prevalence of fractures and osteoporosis in AS. Effect sizes were pooled using fixed- or random-effects models, with subgroup and sensitivity analyses. Publication bias was evaluated using funnel plots and Begg's or Egger's test. A total of 28 studies were included in the final analysis. The overall fracture prevalence in AS patients was 13% (95% CI: 9%-17%), vertebral fracture prevalence was 14% (95% CI: 9%-19%), and osteoporosis prevalence was 14% (95% CI: 10%-19%). AS was significantly associated with vertebral fractures (OR = 2.26; 95% CI: 1.70-3.00) and non-vertebral fractures (OR = 1.24; 95% CI: 1.02-1.50). Among AS assessment indices, BASDAI (OR = 1.05; 95% CI: 1.02-1.08) and mSASSS (OR = 1.04; 95% CI: 1.01-1.06) were significantly associated with fracture risk, while BASFI and BASRI were not. AS significantly increases the risk of fractures and osteoporosis in patients. The BASDAI and mSASSS scoring systems can help predict fracture risk, enabling enhanced early identification and monitoring of complications in AS patients. This approach may ultimately improve long-term health outcomes and quality of life for affected individuals.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Liu Y, Ma X, Dai T, et al. Prevalence and relative risk of fractures and osteoporosis in patients with ankylosing spondylitis: a systematic review and meta-analysis. Osteoporos Int. 2026. PMID: 41575558. doi:10.1007/s00198-025-07838-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。